AbbVie (ABBV) Return on Invested Capital [ROIC] (2013 - 2026)
AbbVie's Return on Invested Capital [ROIC] was 24.28% in Q3 2026, up 11.03 percentage points from 13.25% a year earlier and up 5.60 percentage points from the prior quarter.
Powered by 
Analysis
AbbVie (ABBV) Return on Invested Capital [ROIC] (2013 - 2026) Analysis & Trends
For FY2025, Return on Invested Capital [ROIC] at AbbVie came in at 14.36%, up 1.33 percentage points from FY2024.
- Return on Invested Capital [ROIC] shows a five-year change of -0.05 percentage points (FY2020 to FY2025).
- In earlier years, Return on Invested Capital [ROIC] was 13.03% in FY2024 (-0.21 pp), 13.23% in FY2023 (-5.21 pp), 18.44% in FY2022 (+1.78 pp) and 16.66% in FY2021 (+2.25 pp).
- The Q3 2026 figure marks the highest quarterly Return on Invested Capital [ROIC] since Q4 2019.
- Compared with a year earlier, Return on Invested Capital [ROIC] has increased for seven straight quarters, with an average year-over-year change of +2.63 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Invested Capital [ROIC] over five years was Q3 2026 (a gain of 11.03 percentage points); the worst was Q2 2024 (a drop of 7.67 percentage points).
- Per Business Quant data, ABBV's Return on Invested Capital [ROIC] in the three quarters before Q3 2026 was 18.67% (Q2 2026), 14.32% (Q1 2026) and 14.84% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 30.89% |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 17.57% |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 24.28% |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 2.52% |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 23.11% |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 15.60% |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | -6.11% |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 12.34% |
| 10 | Vertex Pharmaceuticals | 136.55 Bn | 104.28 Bn | 2.91 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 24.28% |
| Jun 30, 2026 | 18.67% |
| Mar 31, 2026 | 14.32% |
| Dec 31, 2025 | 14.84% |
| Sep 30, 2025 | 13.25% |
| Jun 30, 2025 | 15.48% |
| Mar 31, 2025 | 14.20% |
| Dec 31, 2024 | 12.38% |
| Sep 30, 2024 | 12.75% |
| Jun 30, 2024 | 11.65% |
| Mar 31, 2024 | 13.43% |
| Dec 31, 2023 | 13.20% |
| Sep 30, 2023 | 16.18% |
| Jun 30, 2023 | 19.32% |
| Dec 31, 2022 | 19.16% |
| Sep 30, 2022 | 18.53% |
| Jun 30, 2022 | 17.62% |
| Mar 31, 2022 | 18.11% |
| Dec 31, 2021 | 17.10% |
| Sep 30, 2021 | 17.57% |
API Access
AbbVie Return on Invested Capital [ROIC] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=ABBV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-invested-capital-[roic]", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();